Last reviewed · How we verify

NCT04415840

Lugol's Solution in Addition to Acetic Acid During Colposcopy

Completed Last updated 19 July 2022
What this trial tests

trial testing acetic acid test in Uterine Cervical Dysplasia in 323 participants. Completed in 1 July 2021.

Timeline
31 May 2020
Primary endpoint
25 May 2021
1 July 2021

Quick facts

Lead sponsorZydolab - Institute of Cytology and Immune Cytochemistry
StatusCompleted
Study typeOBSERVATIONAL
Enrollment323
Start date31 May 2020
Primary completion25 May 2021
Estimated completion1 July 2021
Sites2 locations across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Zydolab - Institute of Cytology and Immune Cytochemistry

Who can join

Adults 18 to 80, female only, with Uterine Cervical Dysplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the benefits of using Lugol's solution in addition to acetic acid during colposcopy in women with cervical dysplasia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of acetic acid test

Trials testing the same drug.

Other recruiting trials for Uterine Cervical Dysplasia

Currently open trials in the same condition.

Other Zydolab - Institute of Cytology and Immune Cytochemistry trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04415840.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing